Presage Biosciences has announced that they have received a $6 million investment from Takeda and Celgene, as well as appointing a new Chief Executive Officer.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Even in light of the rising fears of “superbugs” in the world of big pharma, the marginal profits made through the development of antibiotics isn’t enough to justify the research.
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.
Chinese investors have poured more money into the US biotech market in the first six months of 2018 than they did in the entirety of last year.
Francisco Ayala, a renowned evolutionary biologist at the University of California, Irvine, has resigned his position after an investigation into sexual harassment allegations against him.
Helix has announced raising $200M in Series B funding, the expansion of the executive team with a new CFO, CMO, and CPO, the acquisition of HumanCode, and a new Denver office.
The U.S. Patent and Trademark Office has decided to grant not just one, but two new CRISPR patents to UC Berkeley, home of pioneer Jennifer Doudna, who many consider the creator of the technology.
The Wellcome Sanger Institute has provided evidence and made recommendations for an inquiry by the UK Parliament Science and Technology Committee into an immigration system that works for science and innovation, following Brexit.
The Swiss drugmaker has clearly noticed the genomic profiling group’s ability to personalise cancer care, now that it will take complete ownership of the company.